Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 10:15:1462526.
doi: 10.3389/fpsyt.2024.1462526. eCollection 2024.

Intranasal dexmedetomidine sedation for EEG in children with autism spectrum disorder

Arianna De Laurentiis  1 , Chiara Pastori  2 , Carmela Pinto  3 , Stefano D'Arrigo  1 , Margherita Estienne  1 , Sara Bulgheroni  1 , Giulia Battaglia  2 , Marco Gemma  3
Affiliations

Intranasal dexmedetomidine sedation for EEG in children with autism spectrum disorder

Arianna De Laurentiis et al. Front Psychiatry. .

Abstract

Introduction: The aim of the study was to assess the efficacy of In-Dex sedation in comparison to oral melatonin and hydroxyzine in individuals with Autism Spectrum Disorder (ASD) undergoing EEG recording and 15 determine which categories of patients exhibit the most favorable response to In-Dex sedation.

Methods: This retrospective observational study involved pediatric patients with ASD who underwent sleep-EEG recording across two periods, before (biennium 2018-19) and after (biennium 2021-22) the routine implementation of In-Dex sedation. Clinical, EEG, and sedation data were stored in a database. A logistic multiple regression model was employed, with the failure of EEG serving as the dependent variable.

Results: In the first period 203 EEGs were performed with a rate of failure of 10.8%, while in the second one 177 EEGs were recorded with a percentage of failure of 7.3% (8.3% with MH 23 sedation and 5.8% with In-Dex sedation). No significant adverse events were reported in either period. Multivariate logistic analysis demonstrated that In-Dex decreased the probability of failure (OR=0.25, 25 (0.61-0.88)), while the presence of behavioral disturbances (OR=3.65((1.54-8.85)) and the use of antipsychotic drugs (OR=2.76, (1.09-6.95)) increased it.

Discussion: In the light of these results, we can state that In-Dex sedation is safe and reduce EEG failure rate compared to the use of melatonin and hydroxyzine alone, particularly in patients with severe behavioral issues.

Keywords: EEG; autism; behavioral disturbance; dexmedetomidine; sedation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th. Arlington, VA: American Psychiatric Association; (2013).
    1. Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, Baulac M, Lechat P, et al. . Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry. (2008) 64:577–82. doi: 10.1016/j.biopsych.2008.04.030 - DOI - PubMed
    1. Lukmanji S, Manji SA, Kadhim S, Sauro KM, Wirrell EC, Kwon CS, et al. . The co-occurrence of epilepsy and autism: A systematic review. Epilepsy Behav. (2019) 98:238–48. doi: 10.1016/j.yebeh.2019.07.037 - DOI - PubMed
    1. Luz-Escamilla L, Morales-González JA. Association between interictal epileptiform discharges and autistic spectrum disorder. Brain Sci. (2019) 9:185. doi: 10.3390/brainsci9080185 - DOI - PMC - PubMed
    1. Hirosawa T, An KM, Soma D, Shiota Y, Sano M, Kameya M, et al. . Epileptiform discharges relate to altered functional brain networks in autism spectrum disorders. Brain Commun. (2021) 3:fcab184. doi: 10.1093/braincomms/fcab184 - DOI - PMC - PubMed